The COVID pandemic is making the need for psychedelic drugs and the commercial potential of the industry much greater. But there is a catch.

Compass is granted two psilocybin formulation patents, for treatment-resistant depression and major depressive disorder.

One huge market. Six horses in the race (so far). Lots of prize money to go around.

Cybin inks a drug development agreement with Catalent, “the leading global provider” of drug delivery, development and manufacturing solutions.

Psychedelic Penny Stocks Continue Gaining Ground Among Mainstream Investors

A top New York senator said that lawmakers and the governor have successfully resolved an outstanding issue in marijuana legalization negotiations related to impaired driving, setting the stage for a formal introduction of new bill text within days.

Andrew Yang, a former 2020 Democratic presidential candidate who is now running for mayor of New York City, said in a recent campaign forum that he supports legalizing psilocybin and marijuana.

Are psychedelics “miracle drugs”? If we compare them to the first Miracle Drug, the answer seems to be “yes”.

MindMed has been added to the FTSE Global Micro-Cap Index and the FTSE Total-Cap Index.